Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evonik Health Care is a leading global Contract Development and Manufacturing Organization (CDMO) and a premier provider of specialty ingredients for the pharmaceutical and biotechnology sectors. As a core business line of Evonik Industries, the company specializes in advanced drug delivery systems, including lipid nanoparticles (LNPs) for mRNA-based therapies and functional polymers for controlled-release formulations. Their comprehensive service portfolio spans from the development and manufacturing of complex active pharmaceutical ingredients (APIs) to the production of finished drug products and medical device components. Evonik is also a major supplier of high-purity cell culture media and amino acids used in the production of biologics and cell therapies. With a global network of R&D and manufacturing sites, the company supports partners in therapeutic areas such as oncology, infectious diseases, and regenerative medicine. Their established brands, including EUDRAGIT and RESOMER, are industry standards for oral and parenteral drug delivery. The company's end-to-end solutions facilitate the transition of innovative therapies from preclinical stages to large-scale commercial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evonik Health Care.